By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
MedsparkMedsparkMedspark
  • Home
  • News & Alerts
    News & AlertsShow More
    Ohio State and Microsoft build a hospital that senses itself
    By
    msadmin
    November 11, 2026
    Charta raises $55M to settle claims before doctors bill
    By
    msadmin
    November 11, 2026
    Oura spends $625M to put doctors behind its ring
    By
    msadmin
    November 11, 2026
    Google puts an agent layer under every hospital workflow
    By
    msadmin
    November 11, 2026
    XtalPi hands Pierre Fabre a molecule factory for stubborn cancer targets
    By
    msadmin
    November 10, 2026
  • Spotlight
    SpotlightShow More
    Robinhood Ventures Fund II brings retail capital to healthcare AI
    By
    msadmin
    August 13, 2026
    Adialante brings accessible MRI-based cancer screening
    By
    msadmin
    August 11, 2026
    CellType models biology so AI can discover drugs
    By
    msadmin
    August 11, 2026
    Healthcare AI startups in Robinhood Ventures Fund II
    By
    msadmin
    August 11, 2026
    OpenAI launches GPT-Rosalind for life sciences research
    By
    msadmin
    July 17, 2026
  • Articles
    ArticlesShow More
    Singapore clinics let an AI watch for referrals nobody ever sent
    By
    msadmin
    November 1, 2026
    An AI team of agents grades immunotherapy side effects
    By
    msadmin
    October 30, 2026
    Brain implant decoders fail when patients or hardware change, review warns
    By
    msadmin
    October 25, 2026
    Proteomics model picks breast cancer drugs from biopsies
    By
    msadmin
    September 10, 2026
    CRISP model reads frozen sections to steer cancer surgery
    By
    msadmin
    September 10, 2026
  • About
    • Mission
    • Services
    • Contact
  • Shop
    • All Items
    • By Category
    • Cart
  • Newsletter
Font ResizerAa
MedsparkMedspark
Font ResizerAa
  • Home
  • News & Alerts
  • Spotlight
  • Articles
  • About
  • Shop
  • Newsletter
  • Home
  • News & Alerts
  • Spotlight
  • Articles
  • About
    • Mission
    • Services
    • Contact
  • Shop
    • All Items
    • By Category
    • Cart
  • Newsletter
Follow US
News & Alerts

Heartflow hauls a second rival into court over cardiac CT software

The FFR-CT pioneer alleges Elucid stole trade secrets and infringed patents, months after suing Cleerly on similar grounds.

MedSpark Staff
By
msadmin
MedSpark Staff
Bymsadmin
Medical, Healthcare, & Biotech/Pharma AI News
Follow:
Published: October 27, 2026
Share
2 Min Read
SHARE

Heartflow sued Elucid on October 22, alleging patent infringement and trade secret theft in the market for AI analysis of coronary CT angiography.

Contents
The regulator as evidenceWhat is really at stake

It is the second such suit this year. Heartflow went after Cleerly in April on similar grounds, claiming the rival used insider knowledge to build competing plaque analysis software.

The Elucid complaint leans on four patents, including No. 9,770,303. At the centre of the case is a regulatory detail: when Elucid filed its 510(k) for FFR-IQ, it named Heartflow’s FFRct as the sole predicate device and described its indications as “same as predicate.”

The regulator as evidence

Predicate-based clearance is routine at the FDA, and naming a competitor’s product is not itself wrongdoing. But Heartflow is using the filing to argue that Elucid defined its own device by reference to Heartflow’s, which makes the infringement claim easier to tell to a jury than a pure software patent fight.

Elucid chief executive Kelly Huang said the Boston company is confident in the independent development of its technology and has spent over a decade building an intellectual property portfolio. It will defend the claims through the courts.

What is really at stake

Software patents are notoriously hard to enforce, so the trade secret count may carry more weight than the patent claims. A Heartflow win would hand it effective control of a segment where several well-funded companies now compete.

Neither company has disclosed damages sought. No trial date has been set.

TAGGED:cardiovascular AIElucidFDA regulationHeartflowMedical Imagingpatent litigation
SOURCES:Cardiac WireBusiness Wire via Yahoo Finance
Share This Article
Facebook Copy Link Print
MedSpark Staff
Bymsadmin
Follow:
Medical, Healthcare, & Biotech/Pharma AI News

You Might Also Like

News & Alerts

Probably Genetic nets $10M to shorten rare disease diagnosis

By
msadmin
September 1, 2026
News & Alerts

HL7 Launches Dedicated AI Office to Drive Global Standards for Ethical Healthcare Innovation

By
Yu Chi Huang
July 8, 2025
News & Alerts

St Vincent’s convenes its own clinicians to police AI adoption

By
msadmin
October 19, 2026
News & Alerts

Mayo Clinic model spots pancreatic cancer 475 days early on routine CT

By
msadmin
October 28, 2026

AI news, analysis, and insights for healthcare, biotech, and pharma.

Facebook Twitter Youtube Linkedin
Quick Links
  • News & Alerts
  • Articles
  • Spotlight
  • Events
About Medspark
  • Mission
  • Services
  • Contact

© Copyright 2026 MedSpark. All rights reserved.

Privacy Policy | Legal